We are live on ! Find out more
CPRX icon

Catalyst Pharmaceutical
CPRX

90 hedge funds and large institutions have $134M invested in Catalyst Pharmaceutical in 2015 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 28 increasing their positions, 27 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

38% more call options, than puts

Call options by funds: $11K | Put options by funds: $8K

25% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 12

3% more funds holding

Funds holding: 87 → 90 (+3)

4% more repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 27

25% less capital invested

Capital invested by funds: $180M → $134M (-$45.6M)

Holders
90
Holders Change
+3
Holders Change %
+3.45%
% of All Funds
2.51%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
28
Reduced
27
Closed
12
Calls
$11K
Puts
$8K
Net Calls
+$3K
Net Calls Change
-$510K

Top Buyers

1
JP Morgan Chase
JP Morgan Chase
New York
+$3.02M
2
Northern Trust
Northern Trust
Illinois
+$2.68M
3
Invesco
Invesco
Georgia
+$1.78M
4
Allianz Asset Management
Allianz Asset Management
Germany
+$1.75M
5
State Street
State Street
Massachusetts
+$1.59M

Top Sellers

1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$5.43M
2
CCA
Catalyst Capital Advisors
New York
-$4.34M
3
Franklin Resources
Franklin Resources
California
-$1.66M
4
Morgan Stanley
Morgan Stanley
New York
-$1.39M
5
PVI
Pura Vida Investments
New York
-$1.27M
Name Holding Trade Value Shares
Change 		Change in
Stake
AIG
51
American International Group
New York
$133K +$224 +52 +0.1%
VOYA Investment Management
52
VOYA Investment Management
Georgia
$127K – – –
California Public Employees Retirement System
53
California Public Employees Retirement System
California
$124K – – –
SCA
54
Secor Capital Advisors
New York
$118K +$170K +39,317 New
AL
55
Agran Libbie
California
$106K +$863 +200 +0.6%
CS
56
Credit Suisse
Switzerland
$104K -$19K -4,412 -11%
RCM
57
Rotella Capital Management
Washington
$103K +$58.3K +13,500 +65%
FANJ
58
Financial Architects (New Jersey)
New Jersey
$90K – – –
Commonwealth Equity Services
59
Commonwealth Equity Services
Massachusetts
$86K -$28.5K -6,600 -19%
SG Americas Securities
60
SG Americas Securities
New York
$85K +$123K +28,400 New
IT
61
Independence Trust
Tennessee
$84K +$121K +28,000 New
SO
62
STRS Ohio
Ohio
$72K – – –
Susquehanna International Group
63
Susquehanna International Group
Pennsylvania
$71K -$25.8K -5,971 -20%
Wells Fargo
64
Wells Fargo
California
$65K +$76.9K +17,814 +472%
GC
65
Guggenheim Capital
Illinois
$59K -$1.8K -417 -2%
NEPWA
66
New England Private Wealth Advisors
Massachusetts
$47K +$67.1K +15,554 New
BNP Paribas Financial Markets
67
BNP Paribas Financial Markets
France
$45.7K +$38.7K +8,962 +143%
PAM
68
Panagora Asset Management
Massachusetts
$45K -$255K -58,988 -80%
BDF
69
Balasa Dinverno & Foltz
$45K +$64.7K +15,000 New
Millennium Management
70
Millennium Management
New York
$41K -$17.3K -3,998 -23%
Principal Financial Group
71
Principal Financial Group
Iowa
$38K +$55K +12,745 New
HSA
72
HBK Sorce Advisory
Pennsylvania
$33K – – –
Legal & General Group
73
Legal & General Group
United Kingdom
$31K +$44.9K +10,410 New
Creative Planning
74
Creative Planning
Kansas
$26K +$37.9K +8,781 New
TRCT
75
Tower Research Capital (TRC)
New York
$24K +$33.7K +7,801 +7,801%
1 2
3
4 5

CPRX Hedge Fund Activity: Q3 2015 in Review

90 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Catalyst Pharmaceutical (CPRX) for Q3 2015, worth a combined $134M — down 25% from $180M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new CPRX positions and 12 closed out — a net gain of 3 holders — while 28 added to existing stakes and 27 trimmed.

The largest buyer was JP Morgan Chase, opening a new position worth an estimated $3.02M. The largest seller was Point72 Asset Management, cutting an estimated $5.43M.

  • 90 institutional investors held Catalyst Pharmaceutical (CPRX) as of Q3 2015, up from 87 in Q2 2015.
  • Funds reported $134M of Catalyst Pharmaceutical stock for Q3 2015, down 25% quarter-over-quarter.
  • 15 funds opened new Catalyst Pharmaceutical positions in Q3 2015 and 12 closed out, a net change of +3 holders.
  • The largest Catalyst Pharmaceutical buyer in Q3 2015 was JP Morgan Chase, an estimated $3.02M added.
  • The largest Catalyst Pharmaceutical seller in Q3 2015 was Point72 Asset Management, an estimated $5.43M sold.

Based on aggregated 13F filings for Q3 2015.